ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc. (CLPT) Stock Overview
Explore ClearPoint Neuro, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
317.4M
P/E Ratio
-14.92
EPS (TTM)
$-0.76
ROE
-0.78%
CLPT Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of ClearPoint Neuro, Inc. (CLPT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 46.01, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $8.43.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -14.92 and a market capitalization of 317.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.